Table 5 Probability of metastasis related to the various T-levels in the three different strategies
TNM | T1A (%) | T1B (%) | T1C (%) | T2(Inf CI) - Palpability Threshold (%) | Palpability Threshold- T2(Sup CI) (%) | T3 (%) |
|---|---|---|---|---|---|---|
32month strategy Pr(CI95%) | 0(0–0) | 3(2–3) | 20(18–21) | 59(55–62) | Over Palpability Threshold, screening loses utility as an early diagnosis tool | |
22month strategy Pr(CI95%) | 0(0–0) | 1(1–1) | 7(6–7) | 30(28–32) | ||
16month strategy Pr(CI95%) | 0(0–0) | 0(0–0) | 1(1–1) | 6(5–6) | ||